Nunziato et al. [4] screened with a multigene panel a cohort of 64 breast/ovarian cancer patients who tested negative for BRCA1/2 screening and with a positive personal and familial history of cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.